A Four-Year-Old 'Butterfly Baby' and the 10,000-Yuan-a-Month Routine Keeping Her Skin Whole
A Hunan girl with epidermolysis bullosa needs bandage changes over most of her body, twice a day, at a cost of over 10,000 yuan a month — and her family's public care logs are teaching China what routine prenatal care misses.
In Xiangtan, Hunan, a four-year-old girl named Chenchen spends two hours a day having bandages changed over nearly her entire body. She has inherited epidermolysis bullosa, or EB — a rare genetic condition affecting roughly one in 17,000 people — and her skin blisters and tears from friction as light as a shirt collar. Chinese families call children like her "butterfly babies" (蝴蝶宝贝): beautiful, and fragile at a touch.
The story trended on Friday after the outlet Shumuwang detailed what her parents' care routine actually costs. Biologic drugs and specialised dressings — some at 160 yuan a sheet, 1,100 yuan a box — push the monthly bill past 10,000 yuan, more than many urban salaries. When Chenchen was newborn, dressing changes took her parents four hours a day; years of practice has cut that to two, and each session consumes at least three packs of dressings for her legs alone. The family's care routine, detailed in the news post, is deliberately public: the parents say they want other rare-disease families to see a working method rather than only sympathy.
The most consequential part of the coverage was not the cost but the genetics. A widely shared explainer walked readers through what routine prenatal care misses: standard ultrasounds and Down-syndrome screening cannot detect EB, because it is caused by any of several gene mutations, and only targeted genetic testing finds it. Families with a history — or who have had one affected child — can test during pregnancy through chorionic villus sampling at 11–14 weeks or amniocentesis at 16–24 weeks, or use pre-implantation genetic testing in IVF to select unaffected embryos before pregnancy. The post's framing was practical rather than fatalistic: with counselling and testing, a family that has had one butterfly baby can plan for a healthy next child.
That detail matters because China's rare-disease families navigate a system where a diagnosis can take years and the drugs are frequently imported and expensive. Chenchen's parents treat biologics and dressings as a regime they will run for her whole childhood; there is no cure, only management, and management at ten thousand yuan a month. The reaction under the news post ran mostly to shock at the dressings' price and admiration for the routine.
EB has no cure, but the care is learnable, the genetics are testable, and the bottleneck is information. A four-year-old in Hunan and her parents are, this week, the country's most visible lesson in that.